Home › Sickle Cell Disease › Florida
Pag-aaral pangklinika para sa Sickle Cell Disease sa Florida
9 pag-aaral para sa Sickle Cell Disease ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
Nagre-recruitPhase 2/3
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- at 4 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
Nagre-recruitPhase 3
Edad 10 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
Nagre-recruitPhase 2
6 Months – 21 Years · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
Nagre-recruitObservasyonal na pag-aaral
Edad 14 hanggang 37 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07373639Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.